Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts

Abstract Drugs targeting multiple stages of the Plasmodium vivax life cycle are needed to reduce the health and economic burdens caused by malaria worldwide. N-myristoyltransferase (NMT) is an essential eukaryotic enzyme and a validated drug target for combating malaria. However, previous PvNMT inhi...

Full description

Bibliographic Details
Main Authors: Diego Rodríguez-Hernández, Kamalakannan Vijayan, Rachael Zigweid, Michael K. Fenwick, Banumathi Sankaran, Wanlapa Roobsoong, Jetsumon Sattabongkot, Elizabeth K. K. Glennon, Peter J. Myler, Per Sunnerhagen, Bart L. Staker, Alexis Kaushansky, Morten Grøtli
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-41119-7
_version_ 1797557907397541888
author Diego Rodríguez-Hernández
Kamalakannan Vijayan
Rachael Zigweid
Michael K. Fenwick
Banumathi Sankaran
Wanlapa Roobsoong
Jetsumon Sattabongkot
Elizabeth K. K. Glennon
Peter J. Myler
Per Sunnerhagen
Bart L. Staker
Alexis Kaushansky
Morten Grøtli
author_facet Diego Rodríguez-Hernández
Kamalakannan Vijayan
Rachael Zigweid
Michael K. Fenwick
Banumathi Sankaran
Wanlapa Roobsoong
Jetsumon Sattabongkot
Elizabeth K. K. Glennon
Peter J. Myler
Per Sunnerhagen
Bart L. Staker
Alexis Kaushansky
Morten Grøtli
author_sort Diego Rodríguez-Hernández
collection DOAJ
description Abstract Drugs targeting multiple stages of the Plasmodium vivax life cycle are needed to reduce the health and economic burdens caused by malaria worldwide. N-myristoyltransferase (NMT) is an essential eukaryotic enzyme and a validated drug target for combating malaria. However, previous PvNMT inhibitors have failed due to their low selectivity over human NMTs. Herein, we apply a structure-guided hybridization approach combining chemical moieties of previously reported NMT inhibitors to develop the next generation of PvNMT inhibitors. A high-resolution crystal structure of PvNMT bound to a representative selective hybrid compound reveals a unique binding site architecture that includes a selective conformation of a key tyrosine residue. The hybridized compounds significantly decrease P. falciparum blood-stage parasite load and consistently exhibit dose-dependent inhibition of P. vivax liver stage schizonts and hypnozoites. Our data demonstrate that hybridized NMT inhibitors can be multistage antimalarials, targeting dormant and developing forms of liver and blood stage.
first_indexed 2024-03-10T17:22:55Z
format Article
id doaj.art-e6b4e2ed37a24eb3abab00e4f5cd5476
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-10T17:22:55Z
publishDate 2023-09-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-e6b4e2ed37a24eb3abab00e4f5cd54762023-11-20T10:17:25ZengNature PortfolioNature Communications2041-17232023-09-0114111310.1038/s41467-023-41119-7Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizontsDiego Rodríguez-Hernández0Kamalakannan Vijayan1Rachael Zigweid2Michael K. Fenwick3Banumathi Sankaran4Wanlapa Roobsoong5Jetsumon Sattabongkot6Elizabeth K. K. Glennon7Peter J. Myler8Per Sunnerhagen9Bart L. Staker10Alexis Kaushansky11Morten Grøtli12Department of Chemistry and Molecular Biology, University of Gothenburg; S-405 30Center for Global Infectious Disease Research, Seattle Children’s Research InstituteCenter for Global Infectious Disease Research, Seattle Children’s Research InstituteCenter for Global Infectious Disease Research, Seattle Children’s Research InstituteMolecular Biophysics and Integrated Bioimaging, Berkeley Center for Structural Biology, Advanced Light Source; Berkeley National LaboratoryMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol UniversityMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol UniversityCenter for Global Infectious Disease Research, Seattle Children’s Research InstituteCenter for Global Infectious Disease Research, Seattle Children’s Research InstituteDepartment of Chemistry and Molecular Biology, University of Gothenburg; S-405 30Center for Global Infectious Disease Research, Seattle Children’s Research InstituteCenter for Global Infectious Disease Research, Seattle Children’s Research InstituteDepartment of Chemistry and Molecular Biology, University of Gothenburg; S-405 30Abstract Drugs targeting multiple stages of the Plasmodium vivax life cycle are needed to reduce the health and economic burdens caused by malaria worldwide. N-myristoyltransferase (NMT) is an essential eukaryotic enzyme and a validated drug target for combating malaria. However, previous PvNMT inhibitors have failed due to their low selectivity over human NMTs. Herein, we apply a structure-guided hybridization approach combining chemical moieties of previously reported NMT inhibitors to develop the next generation of PvNMT inhibitors. A high-resolution crystal structure of PvNMT bound to a representative selective hybrid compound reveals a unique binding site architecture that includes a selective conformation of a key tyrosine residue. The hybridized compounds significantly decrease P. falciparum blood-stage parasite load and consistently exhibit dose-dependent inhibition of P. vivax liver stage schizonts and hypnozoites. Our data demonstrate that hybridized NMT inhibitors can be multistage antimalarials, targeting dormant and developing forms of liver and blood stage.https://doi.org/10.1038/s41467-023-41119-7
spellingShingle Diego Rodríguez-Hernández
Kamalakannan Vijayan
Rachael Zigweid
Michael K. Fenwick
Banumathi Sankaran
Wanlapa Roobsoong
Jetsumon Sattabongkot
Elizabeth K. K. Glennon
Peter J. Myler
Per Sunnerhagen
Bart L. Staker
Alexis Kaushansky
Morten Grøtli
Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts
Nature Communications
title Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts
title_full Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts
title_fullStr Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts
title_full_unstemmed Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts
title_short Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts
title_sort identification of potent and selective n myristoyltransferase inhibitors of plasmodium vivax liver stage hypnozoites and schizonts
url https://doi.org/10.1038/s41467-023-41119-7
work_keys_str_mv AT diegorodriguezhernandez identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT kamalakannanvijayan identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT rachaelzigweid identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT michaelkfenwick identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT banumathisankaran identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT wanlaparoobsoong identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT jetsumonsattabongkot identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT elizabethkkglennon identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT peterjmyler identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT persunnerhagen identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT bartlstaker identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT alexiskaushansky identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts
AT mortengrøtli identificationofpotentandselectivenmyristoyltransferaseinhibitorsofplasmodiumvivaxliverstagehypnozoitesandschizonts